EspañolPharmacovigilance is a public health activity focus on the identification, assessment and prevention of adverse reactions for marketed drugs. An Adverse Reaction is defined as any undesirable effect which appears after the administration of a drug.
In order to achieve this goal, a close collaboration is required among the different parts involved in the use of the medicine (pharmaceutical companies, health professionals, health authorities and patients).
In this way, and faithful to our commitment for improving health and quality of life of patients and ensure their safety, Chemo group, in compliance with current legislation, provides a system for reporting Adverse Drug Reactions, in order to inform to the relevant health authorities and take appropriate measures.
To report a human adverse drug reaction:
E-mail: pharmacovigilance@chemogroup.net
Tel: +34 619 275 590 (contact 24 hours)
Fax: +34 913 848 306
Pursuant to the provisions of Law 15/1999 of December 13, Protection of Personal Data, LABORATORY LICONSA SA., Informs you that your personal data provided by you will form part of the file which PHARMACOVIGILANCE society is responsible.
These data are collected and stored with the legal purpose of collecting adverse drug events to evaluate its benefit / risk.
You can exercise your rights of access, rectification, cancellation and opposition to the processing of data through written communication to the following address NECTAR BUILDING C / Quintanapalla No. 2 4th Floor (CHEMO). D.P. 28050 .- Madrid.
To report a veterinary adverse drug reaction:
E-mail: vet_pharmacovigilance@chemogroup.net
Tel: +34 608 589 898 (contact 24 hours)
Fax: +34 933 302 650